Mati is the CEO of AION Labs, an Israel-based innovation lab using AI for drug discovery and development, a coalition between Pfizer, Amazon Web Services (AWS), AstraZeneca, Teva, Merck and the Israel Biotech Fund (IBF). Mati has held leadership roles within the biopharma industry for over a decade, formerly serving as a senior executive at Teva Pharmaceuticals. Prior to his term in industry, Mati was Chief of Staff for Israel’s Minister of Public Security.
